David Ku, M.D., Ph.D. serves as the Executive Director of APDC and is the Lawrence P. Huang Chair Professor of Engineering Entrepreneurship, a Regents' Professor of Mechanical Engineering, and Director of the Center for Entrepreneurship's Program for Engineering Entrepreneurship at Georgia Tech. He has an active research interest in cardiovascular disease pathophysiology and treatment. He has additional interest in commercialization of novel medical devices through start-up companies, and efficient methods of product development. He has been involved with four start-ups and successfully raised over $20 million in private financing.

Barbara D. Boyan, Ph.D. is a director of the Atlanta Pediatric Device Consortium and Dean of the School of Engineering at Virginia Commonwealth University.  She was previously a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University in Atlanta, Georgia where she held the Price Gilbert, Jr. Chair in Tissue Engineering. She was a Georgia Research Alliance Eminent Scholar and Associate Dean for Research in the College of Engineering. In 1993, she co-founded OsteoBiologics, Inc. (San Antonio, Texas), which was acquired by Smith & Nephew in 2007. Dr. Boyan is also founder of Biomedical Development Corporation in San Antonio, as well as Orthonics, Inc. and SpherIngenics, Inc. in Atlanta. She sits on the Board of Directors of Arthrocare, Inc. (Austin, TX) and Carticept Medical, Inc. (Alpharetta, GA). The author of more than 370 peer-reviewed papers, reviews, and book chapters, Dr. Boyan holds 13 U.S. patents.

Kevin Maher, M.D. serves as a Director for the APDC and is a pediatric cardiologist at Children’s Healthcare of Atlanta.  He is an Associate Professor of Pediatrics at Emory University School of Medicine and an Adjunct Associate Professor of Biomedical Engineering at Georgia Tech.  He is the Director of the Pediatric Cardiac Intensive Care Unit, the Co-director of Center for Pediatric Innovation at Children's and Georgia Tech and serves on the Board of Directors for the Global Center for Medical Innovation and the Petit Institute of Biomedical Engineering and Bioscience at Georgia Tech. 

Wilbur Lam, M.D., Ph.D. serves as a Director of APDC and is a bioengineer and pediatric hematologist/oncologist.  He is Assistant Professor in the Department of Pediatrics at Emory University School of Medicine and in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech, where he is developing and applying novel technologies using micro/nanotechnology, microfluidics, and cell mechanics to research, diagnose, and treat blood diseases and cancer.  Dr. Lam is also involved in the invention, development, and clinical assessment of novel medical diagnostics for childhood diseases.  His laboratory has numerous publications and grant support for those projects with a filed patent and spin-off company, CellScope Inc., stemming from his work.

L. Franklin Bost, M.B.A. IDSA, serves as the Director of Educational Programs for APDC. He is the Executive Associate Dean in Engineering and the Executive Director of the Translational Research Innovation Projects (TRIP) at VCU.  Mr. Bost is also the president and chief executive officer of SpherIngenics Inc., an early stage device company focusing on enhancing the delivery and effectiveness of stem cell therapies.  Previously, he was Professor of the Practice in biomedical engineering at Georgia Tech when APDC was awarded its original P50 grant. In his industry career, Mr. Bost was president of Porex Surgical Inc., a developer, manufacturer and distributor of implantable biomaterial products for craniofacial reconstructive surgery and previously served in executive management and development positions with several large medical device companies.